BRIEF: Bao Pharma doubles in Hong Kong trading debut
Shares Shanghai Bao Pharmaceuticals Co. Ltd. (2659.HK) opened up 128% in their Hong Kong trading debut on Wednesday, and held on to the gains during the morning session to close…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
BRIEF: Wai Yuen Tong’s profit plunges in first half of fiscal year
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or…
BRIEF: Haixi Pharma delays IPO trading debut
Fujian Haixi Pharmaceuticals Co. Ltd. (2637.HK) said on Thursday night that the trading debut for its Hong Kong IPO, originally scheduled for Friday, will be postponed. It blamed the delay…
BRIEF: Xuanzhu Biopharma launches IPO to raise $100 million
Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK), spun off from Sihuan Pharma (0460.HK), launched its IPO on Monday, aiming to sell 67.3 million shares for HK$11.60 each to raise HK$780 million ($100…
BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO
Pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) on Friday launched its Hong Kong IPO, seeking to raise about HK$601 million ($77 million) by selling 41.2 million shares for HK$14.75 apiece. The…